Growth Opportunities in European Healthcare EDI Market

1. European Healthcare EDI Market by Type (Endocrine, Paracrine), Pathway (Akt, AMPK, Hedgehog, Notch), Product (Consumables, Instruments), Technology (Flow Cytometry, ELISA, Mass Spectrometry) & Application (Research, Cancer, Immunology) - Global Forecast to 2022 According to the new market research report "European Healthcare EDI Market by Supplier (Distributors and Wholesalers, GPOS, Manufacturers), Purchasing Organization (Hospitals, GPOS), Transaction (Orders, Ordersp, Desadv, Recadv, Invoic) Transaction Types and Its Penetration", published by MarketsandMarkets™ The European healthcare electronic data interchange (EDI) market recorded a healthy growth rate during the last decade, owing to technological advancements and increasing adoption of healthcare EDI solutions among healthcare providers, suppliers, and purchasing organizations across Europe. Hospitals across Europe are increasingly taking several initiatives due to high pressure for healthcare cost reduction in the current dynamic environment. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=93400242 Supply chain costs are at the focus of cost optimization strategies in hospitals across Europe. To achieve operational benefits in supply chain management, hospitals are attempting to attain closer relationships with their suppliers/vendors through utilization of inter- organizational information systems such as EDI. Hospitals use EDI more often with distributor orders than manufacturer-direct orders. Browse and in-depth TOC on “European Healthcare EDI Market” 157 - Tables 76 - Figures 212 - Pages In this report, the European healthcare EDI market is segmented based on type of transaction, type of purchasing organization, and region. The European healthcare EDI market is analyzed at regional and country level comprising Benelux, Denmark, France, Germany, Italy, Spain, Sweden, Switzerland, and the U.K. The healthcare markets in Germany, France, Denmark, and Sweden are expected to witness a high penetration rate for EDI in coming years owing to the rising geriatric population, increasing government funding and initiatives, improving healthcare infrastructure, increasing demand for quality healthcare at low costs, and presence of major companies in these regions. Bayer AG, Pfizer Inc., GlaxoSmithKline PLC, and Abbott Laboratories are the EDI technology leaders in the pharmaceutical and manufacturing sector in Europe. Read More in Detailed: https://www.marketsandmarkets.com/PressReleases/european-healthcare- edi.asp The EDI penetration rate was highest in U.K., followed by France, Benelux, Denmark, and Germany. ORDERS, ORDERSP, DESADV, RECADV, and INVOIC are the most popular healthcare EDI transactions in Europe. Among all European countries, the penetration rate of hospital EDI for ORDERS transactions with distributors was highest in the U.K. in 2015.

2. There has been a considerable rise in EDI adoption among GPOs and hospitals in Europe over the last few years. Increasing number of hospitals adopting EDI solutions, operational benefits and increased speed of transaction processing, growing utilization of EDI solutions in supply chain management are the factors contributing to the growth of healthcare EDI market in Europe. The increasing use of EDI in healthcare manufacturing & distribution industry and gradual acceptance of mobile EDI are the major trends in the European healthcare EDI market. About MarketsandMarkets™ MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions. Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve. MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. Contact Us: Mr. Shelly Singh MarketsandMarkets™ INC. 630 Dundee Road Suite 430 Northbrook, IL 60062 USA: +1-888-600-6441 Email: sales@marketsandmarkets.com Research Insight: https://www.marketsandmarkets.com/ResearchInsight/cell-signaling- market.asp Visit Our Website: https://www.marketsandmarkets.com